Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC26A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFOX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SCAMP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGDR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR2DS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF625-ZNF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNJ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR2DS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on